Literature DB >> 33603837

Effects of melatonin on protecting against lung injury (Review).

Weiwei Wang1, Ju Gao1.   

Abstract

Melatonin (MT; N-acetyl-5-methoxy-tryptamine), which has multiple effects and roles, is secreted from the pineal gland at night according to the daily rhythm. In addition to circadian regulation, MT has anti-inflammatory, antioxidant and anticancer functions. Recent studies postulated that MT serves a critical role in apoptosis, anti-ischemic reperfusion injury and anti-proliferative effects on various cells. The current review reported on the underlying mechanism behind the protective effect of MT on lung diseases, such as acute lung injury, acute respiratory distress syndrome, chronic obstructive pulmonary disease, lung ischemia-reperfusion injury, sepsis-induced lung injury and ventilator-induced lung injury. MT is considered an adjuvant with therapeutic drugs for preventing inflammation and is responsible for regulating patient sleep cycles in the intensive care unit. The current review described the anti-inflammatory and antioxidant efficiency of MT with a focus on the molecular mechanisms of action in various lung injuries.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  acute lung injury; chronic obstructive pulmonary disease; melatonin; ventilator-induced lung injury

Year:  2021        PMID: 33603837      PMCID: PMC7851611          DOI: 10.3892/etm.2021.9659

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  111 in total

1.  [Asthma management: overview and new aspects].

Authors:  C Steurer-Stey
Journal:  Praxis (Bern 1994)       Date:  2007-12-05

2.  Intraoperative ventilation settings and their associations with postoperative pulmonary complications in obese patients.

Authors:  L Ball; S N T Hemmes; A Serpa Neto; T Bluth; J Canet; M Hiesmayr; M W Hollmann; G H Mills; M F Vidal Melo; C Putensen; W Schmid; P Severgnini; H Wrigge; M Gama de Abreu; M J Schultz; P Pelosi
Journal:  Br J Anaesth       Date:  2018-06-02       Impact factor: 9.166

3.  Melatonin protects against COPD by attenuating apoptosis and endoplasmic reticulum stress via upregulating SIRT1 expression in rats.

Authors:  Baimei He; Wenxuan Zhang; Jianfeng Qiao; Zhenyu Peng; Xiangping Chai
Journal:  Can J Physiol Pharmacol       Date:  2019-01-23       Impact factor: 2.273

4.  Melatonin reduces acute lung inflammation, edema, and hemorrhage in heatstroke rats.

Authors:  Wen-shiann Wu; Ming-ting Chou; Chien-ming Chao; Chen-kuei Chang; Mao-tsun Lin; Ching-ping Chang
Journal:  Acta Pharmacol Sin       Date:  2012-05-21       Impact factor: 6.150

5.  Effects of some low molecular weight sheep pineal fractions and melatonin on different tumors in rats and mice.

Authors:  V Lapin; I Ebels
Journal:  Oncology       Date:  1976       Impact factor: 2.935

6.  The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Vahidreza Ostadmohammadi; Alireza Soleimani; Fereshteh Bahmani; Esmat Aghadavod; Reza Ramezani; Russel J Reiter; Mohammad Ali Mansournia; Zarrin Banikazemi; Maryam Soleimani; Marsa Zaroudi; Zatollah Asemi
Journal:  J Ren Nutr       Date:  2019-10-06       Impact factor: 3.655

7.  Cyclic-3-hydroxymelatonin (C3HOM), a potent antioxidant, scavenges free radicals and suppresses oxidative reactions.

Authors:  Dun-Xian Tan; R Hardeland; L C Manchester; A Galano; R J Reiter
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

8.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure.

Authors:  Evangelos J Giamarellos-Bourboulis; Mihai G Netea; Nikoletta Rovina; Karolina Akinosoglou; Anastasia Antoniadou; Nikolaos Antonakos; Georgia Damoraki; Theologia Gkavogianni; Maria-Evangelia Adami; Paraskevi Katsaounou; Maria Ntaganou; Magdalini Kyriakopoulou; George Dimopoulos; Ioannis Koutsodimitropoulos; Dimitrios Velissaris; Panagiotis Koufargyris; Athanassios Karageorgos; Konstantina Katrini; Vasileios Lekakis; Mihaela Lupse; Antigone Kotsaki; George Renieris; Danai Theodoulou; Vassiliki Panou; Evangelia Koukaki; Nikolaos Koulouris; Charalambos Gogos; Antonia Koutsoukou
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

9.  Role of melatonin as an SIRT1 enhancer in chronic obstructive pulmonary disease induced by cigarette smoke.

Authors:  Na-Rae Shin; Je-Won Ko; Jong-Choon Kim; Gunhyuk Park; Sung-Hwan Kim; Min-Seok Kim; Joong-Sun Kim; In-Sik Shin
Journal:  J Cell Mol Med       Date:  2019-11-25       Impact factor: 5.310

Review 10.  From Implantation to Birth: Insight into Molecular Melatonin Functions.

Authors:  Gianfranco Carlomagno; Mirko Minini; Marco Tilotta; Vittorio Unfer
Journal:  Int J Mol Sci       Date:  2018-09-17       Impact factor: 5.923

View more
  4 in total

Review 1.  Melatonin as a Potential Adjuvant Treatment for COVID-19 beyond Sleep Disorders.

Authors:  Adam Wichniak; Aleksander Kania; Mariusz Siemiński; Wiesław Jerzy Cubała
Journal:  Int J Mol Sci       Date:  2021-08-11       Impact factor: 5.923

Review 2.  The Link between Circadian Clock Genes and Autophagy in Chronic Obstructive Pulmonary Disease.

Authors:  Yuedi Hu; Tiantian He; Jie Zhu; Xiaole Wang; Jiabing Tong; Zegeng Li; Jingcheng Dong
Journal:  Mediators Inflamm       Date:  2021-10-25       Impact factor: 4.711

Review 3.  Role of melatonin in respiratory diseases (Review).

Authors:  Lijie Li; Xiaochao Gang; Jiajia Wang; Xiaoyan Gong
Journal:  Exp Ther Med       Date:  2022-02-09       Impact factor: 2.447

Review 4.  Dysregulated Cell Signaling in Pulmonary Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Beata Kosmider
Journal:  Front Med (Lausanne)       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.